Key points are not available for this paper at this time.
Biological drugs intended for multi-dose application require the presence of antimicrobial preservatives to avoid microbial growth. As the presence of certain preservatives has been reported to increase protein and peptide particle formation, it is essential to choose a preservative compatible with the active pharmaceutical ingredient in addition to its preservation function. Thus, this review describes the current status of the use of antimicrobial preservatives in biologic formulations considering (i) appropriate preservatives for protein and peptide formulations, (ii) their physico-chemical properties, (iii) their in-/compatibilities with other excipients or packaging material, and (iv) their interactions with the biological compound. Further, (v) we present an overview of licensed protein and peptide formulations.
Building similarity graph...
Analyzing shared references across papers
Loading...
Luisa Stroppel
Boehringer Ingelheim (Germany)
Torsten Schultz‐Fademrecht
Boehringer Ingelheim (Germany)
Martin Cebulla
Boehringer Ingelheim (Germany)
SHILAP Revista de lepidopterología
Pharmaceutics
University of Tübingen
Boehringer Ingelheim (Germany)
Building similarity graph...
Analyzing shared references across papers
Loading...
Stroppel et al. (Tue,) studied this question.
synapsesocial.com/papers/69d80b3133ca018b39ae31b4 — DOI: https://doi.org/10.3390/pharmaceutics15020563
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: